Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including 1-year survival: results from the do tirofiban and ReoPro give similar efficacy outcome trial (TARGET)

✍ Scribed by A.W Chan; D.J Moliterno; P.B Berger

• Book ID: 113413821
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 42 KB
• Volume: 13
• Category: Article
• ISSN: 1062-1458
• DOI: 10.1016/j.accreview.2003.10.052